<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
<record>
  <controlfield tag="001">112188</controlfield>
  <controlfield tag="005">20240319080958.0</controlfield>
  <datafield tag="024" ind1="7" ind2=" ">
    <subfield code="2">doi</subfield>
    <subfield code="a">10.3390/cancers14071828</subfield>
  </datafield>
  <datafield tag="024" ind1="8" ind2=" ">
    <subfield code="2">sideral</subfield>
    <subfield code="a">128327</subfield>
  </datafield>
  <datafield tag="037" ind1=" " ind2=" ">
    <subfield code="a">ART-2022-128327</subfield>
  </datafield>
  <datafield tag="041" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Morote, Juan</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2022</subfield>
  </datafield>
  <datafield tag="506" ind1="0" ind2=" ">
    <subfield code="a">Access copy available to the general public</subfield>
    <subfield code="f">Unrestricted</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
    <subfield code="a">We sought to find further evidence showing the increase in PCa aggressiveness as PI-RADS score increases from four surrogates of PCa aggressiveness: i. prostate biopsy GG (≤3 vs. &amp;gt;3), ii. type of pathology in surgical specimens (favourable vs. unfavourable), iii. clinical stage (localised vs. advanced), and risk of recurrence of localised PCa after primary treatment (low-intermediate vs. high). A group of 692 PCa patients were diagnosed after 3-T multiparametric MRI (mpMRI) and guided and/or systematic biopsies, showing csPCa (GG ≥ 2) in 547 patients (79%) and insignificant PCa (iPCa) in 145 (21%). The csPCa rate increased from 32.4% in PI-RADS &amp;lt; 3 to 95.5% in PI-RADS 5 (p &amp;lt; 0.001). GG ≥ 3 was observed in 7.6% of PCa with PI-RADS &amp;lt; 3 and 32.6% in those with PI-RADS &amp;gt; 3 (p &amp;lt; 0.001). Unfavourable pathology was observed in 38.9% of PCa with PI-RAD &amp;lt; 3 and 68.3% in those with PI-RADS &amp;gt; 3 (p = 0.030). Advanced disease was not observed in PCa with PI-RADS ≤ 3, while it existed in 12.7% of those with PI-RADS &amp;gt; 3 (p &amp;lt; 0.001). High-risk recurrence localised PCa was observed in 9.5% of PCa with PI-RADS &amp;lt; 3 and 35% in those with PI-RADS &amp;gt; 3 (p = 0.001). The PI-RADS score was an independent predictor of all surrogates of PCa aggressiveness as PSA density. We confirmed that mpMRI grades PCa aggressiveness.</subfield>
  </datafield>
  <datafield tag="536" ind1=" " ind2=" ">
    <subfield code="9">info:eu-repo/grantAgreement/ES/ISCIII/PI20/01666</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="9">info:eu-repo/semantics/openAccess</subfield>
    <subfield code="a">by</subfield>
    <subfield code="u">http://creativecommons.org/licenses/by/3.0/es/</subfield>
  </datafield>
  <datafield tag="590" ind1=" " ind2=" ">
    <subfield code="a">5.2</subfield>
    <subfield code="b">2022</subfield>
  </datafield>
  <datafield tag="591" ind1=" " ind2=" ">
    <subfield code="a">ONCOLOGY</subfield>
    <subfield code="b">72 / 241 = 0.299</subfield>
    <subfield code="c">2022</subfield>
    <subfield code="d">Q2</subfield>
    <subfield code="e">T1</subfield>
  </datafield>
  <datafield tag="592" ind1=" " ind2=" ">
    <subfield code="a">1.312</subfield>
    <subfield code="b">2022</subfield>
  </datafield>
  <datafield tag="593" ind1=" " ind2=" ">
    <subfield code="a">Oncology</subfield>
    <subfield code="c">2022</subfield>
    <subfield code="d">Q1</subfield>
  </datafield>
  <datafield tag="593" ind1=" " ind2=" ">
    <subfield code="a">Cancer Research</subfield>
    <subfield code="c">2022</subfield>
    <subfield code="d">Q2</subfield>
  </datafield>
  <datafield tag="594" ind1=" " ind2=" ">
    <subfield code="a">7.4</subfield>
    <subfield code="b">2022</subfield>
  </datafield>
  <datafield tag="655" ind1=" " ind2="4">
    <subfield code="a">info:eu-repo/semantics/article</subfield>
    <subfield code="v">info:eu-repo/semantics/publishedVersion</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Borque-Fernando, Angel</subfield>
    <subfield code="u">Universidad de Zaragoza</subfield>
    <subfield code="0">(orcid)0000-0003-0178-4567</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Triquell, Marina</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Celma, Anna</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Regis, Lucas</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Mast, Richard</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">de Torres, Inés M.</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Semidey, María E.</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Santamaría, Anna</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Planas, Jacques</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Esteban, Luis M.</subfield>
    <subfield code="0">(orcid)0000-0002-3007-302X</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Trilla, Enrique</subfield>
  </datafield>
  <datafield tag="710" ind1="2" ind2=" ">
    <subfield code="1">1013</subfield>
    <subfield code="2">817</subfield>
    <subfield code="a">Universidad de Zaragoza</subfield>
    <subfield code="b">Dpto. Cirugía</subfield>
    <subfield code="c">Área Urología</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="g">14, 7 (2022), 1828 [9 p.]</subfield>
    <subfield code="p">Cancers</subfield>
    <subfield code="t">Cancers</subfield>
    <subfield code="x">2072-6694</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">619453</subfield>
    <subfield code="u">http://zaguan.unizar.es/record/112188/files/texto_completo.pdf</subfield>
    <subfield code="y">Versión publicada</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">2647704</subfield>
    <subfield code="u">http://zaguan.unizar.es/record/112188/files/texto_completo.jpg?subformat=icon</subfield>
    <subfield code="x">icon</subfield>
    <subfield code="y">Versión publicada</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zaguan.unizar.es:112188</subfield>
    <subfield code="p">articulos</subfield>
    <subfield code="p">driver</subfield>
  </datafield>
  <datafield tag="951" ind1=" " ind2=" ">
    <subfield code="a">2024-03-18-13:54:03</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">ARTICLE</subfield>
  </datafield>
</record>
</collection>